Ampio Pharmaceuticals, Inc.
|Number of Estimates|
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.
Market Cap: 79.4 Million
Primary Exchange: NYSE American
Shares Outstanding: 159 Million
Float: 145 Million
Sector: Health Technology
Industry: Pharmaceuticals: Other
Longest drawdown: 1633 trading days
From: 2013-10-24 To: 2020-04-02
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|